In addition to positive heart health effects, it helps cut your risk of cancer, too, new research suggests.

Aspirin can reduce the chances of dying from bowel cancer by almost a third, research has shown.

Neither aspirin nor warfarin is superior for preventing a combined risk of death, stroke, and cerebral hemorrhage in heart failure patients with normal heart rhythm, according to a landmark clinical trial published in today's New England Journal of Medicine.

Neither aspirin nor warfarin is superior for preventing a combined risk of death, stroke, and cerebral hemorrhage in heart failure patients with normal heart rhythm, according to a landmark clinical trial.

Taking aspirin daily after being diagnosed with bowel cancer can reduce the chances of dying by almost a third, research has shown.

Bowel cancer patients who take aspirin daily could cut their chance of dying from the disease by about a third, experts believe.

Aspirin can reduce the chances of dying from bowel cancer by almost a third, research has shown.

Aspirin could be just as good as more expensive drugs for patients with heart failure, say researchers from Columbia University.

There is previous evidence suggesting aspirin might prevent certain cancers from developing in the first place. And more recent work suggests it might also work as a cancer therapy - slowing down or preventing a cancer's spread. But the drug can also have unpleasant and dangerous side effects, causing irritation of the stomach lining and internal bleeds in a very small minority of patients.

Less costly aspirin is as effective for heart failure patients with normal heart rhythm as other more expensive drugs, such as warfarin, according to breakthrough research published in today’s New England Journal of Medicine . Researchers, led by clinical principal investigator Shunichi Homma, MD, of Columbia University Medical Center in New York and statistical principal investigator John L.P ...